ArticleOncotarget2018

Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.

Emelie Karnevi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.